23andMe

Prenetics, a Hong Kong-based startup that offers genetic testing services for patients, is expanding outside of Asia and into the consumer space after it acquired London-based company DNAFit. The deal

Disrupt SF might feel familiar to many of you, but I encourage you to be prepared for a surprise. The world’s most impactful tech startup conference is about to get bigger and better than ever.

Genetic testing powerhouse 23andMe announced today that it's officially received the FDA go-ahead to launch a direct-to-consumer testing kit for genes linked to various forms of cancer. The forthcomin

Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c

The blockchain is the buzziest thing on the internet these days and now MIT professor and godfather of the Human Genome Project George Church wants to put your genes on it. His new startup Nebula Geno

A really awesome thing about being black is that ancestry can be very unclear because of, you know, slavery. Enter DNA kits.

Genetics testing company 23andMe has formally announced that Sequoia Capital is leading an investment round in the company. This confirms the news we broke last week.  The press release says that the

The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f

[protected-iframe id=”bea37dd2e994b6235fdc3c682961f2cd-24588526-321129″ info=”https://simplecast.com/e/c9f27b18?style=large” width=”100%” height=”330px”

Following up on the news of 23andMe’s huge upcoming financing round, TechCrunch has learned that the company is raising the new financing at a $1.5 billion pre-money valuation. This compares to

23andMe, the Mountain View-based genetic testing and analysis company, is raising close to $200 million in a funding round led by Sequoia Capital, multiple sources tell us. Sources say that Fidelity i

TechCrunch Disrupt SF 2017 is less than a month away at Pier 48 in San Francisco. This year's lineup includes a stellar group of speakers, including Pinterest's Ben Silbermann, Golden State Warriors s

Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, to

There are a number of ways to find out more about your fertility these days -- including from several at-home fertility test startups that have started to pop up in the last few years. Modern Fertili

Discovering your heritage is just a spit-tube away these days, thanks to the pioneering efforts 23andMe, the OG of at-home DNA tests. The decade-old company forged the path towards consumer access to

There's a lot going on in commercial DNA testing these days beyond what eye color you have or where your mitochondria comes from, and at-home lab testing startup EverlyWell hopes to cash in. The start

Ever wanted to know the genetic mix of your mutt? Embark, a doggie DNA startup has raised $4.5 million in seed to expand its offering of genetic kits for your pup’s pedigree. Embark launched in

It’s easier than ever to skip the doctor and go straight for the at-home test these days, thanks to updated regulations and the technology to match — and for many, it’s the answer to

The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, includi